Genomic and lipidomic analyses differentiate the compensatory roles of two COX isoforms during systemic inflammation in mice1,2[S]

Both cyclooxygenase (COX)-1 and COX-2, encoded by Ptgs1 and Ptgs2, function coordinately during inflammation. But the relative contributions and compensations of COX-1 and COX-2 to inflammatory responses remain unanswered. We used three engineered mouse lines where the Ptgs1 and Ptgs2 genes substitute for one another to discriminate the distinct roles and interchangeability of COX isoforms during systemic inflammation. In macrophages, kidneys, and lungs, “flipped” Ptgs genes generate a “reversed” COX expression pattern, where the knock-in COX-2 is expressed constitutively and the knock-in COX-1 is lipopolysaccharide inducible. A panel of eicosanoids detected in serum and kidney demonstrates that prostaglandin (PG) biosynthesis requires native COX-1 and cannot be rescued by the knock-in COX-2. Our data further reveal preferential compensation of COX isoforms for prostanoid production in macrophages and throughout the body, as reflected by urinary PG metabolites. NanoString analysis indicates that inflammatory networks can be maintained by isoform substitution in inflamed macrophages. However, COX-1>COX-2 macrophages show reduced activation of inflammatory signaling pathways, indicating that COX-1 may be replaced by COX-2 within this complex milieu, but not vice versa. Collectively, each COX isoform plays a distinct role subject to subcellular environment and tissue/cell-specific conditions, leading to subtle compensatory differences during systemic inflammation.

[1]  G. FitzGerald,et al.  Flipping the cyclooxygenase (Ptgs) genes reveals isoform-specific compensatory functions1,2[S] , 2017, Journal of Lipid Research.

[2]  D. Engblom,et al.  Prostaglandin-mediated inhibition of serotonin signaling controls the affective component of inflammatory pain , 2017, The Journal of clinical investigation.

[3]  D. Engblom,et al.  Cyclooxygenase Isoform Exchange Blocks Brain-Mediated Inflammatory Symptoms , 2016, PloS one.

[4]  J. Mitchell,et al.  Aspirin inhibits the production of proangiogenic 15(S)-HETE by platelet cyclooxygenase-1 , 2016, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[5]  Hailiang Huang,et al.  Characterization of candidate genes in inflammatory bowel disease-associated risk loci. , 2016, JCI insight.

[6]  Roderick V. Jensen,et al.  Genomic, Lipidomic and Metabolomic Analysis of Cyclooxygenase-null Cells: Eicosanoid Storm, Cross Talk, and Compensation by COX-1 , 2016, Genom. Proteom. Bioinform..

[7]  J. Cidlowski,et al.  Endogenous hepatic glucocorticoid receptor signaling coordinates sex‐biased inflammatory gene expression , 2016, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[8]  M. Reilly,et al.  Bioactive products formed in humans from fish oils1[S] , 2015, Journal of Lipid Research.

[9]  Charles N. Serhan,et al.  Pro-resolving lipid mediators are leads for resolution physiology , 2014, Nature.

[10]  C. Funk,et al.  Cyclooxygenase‐2 induction in macrophages is modulated by docosahexaenoic acid via interactions with free fatty acid receptor 4 (FFA4) , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[11]  P. Boor,et al.  YB-1 Is an Early and Central Mediator of Bacterial and Sterile Inflammation In Vivo , 2013, The Journal of Immunology.

[12]  Myeong Sup Lee,et al.  Genome-wide profiling of in vivo LPS-responsive genes in splenic myeloid cells , 2013, Molecules and cells.

[13]  M. Ornatowska,et al.  Lipopolysaccharide-Induced Expression of Microsomal Prostaglandin E Synthase-1 Mediates Late-Phase PGE2 Production in Bone Marrow Derived Macrophages , 2012, PloS one.

[14]  A. A. Romanovsky,et al.  Neural Circuitry Engaged by Prostaglandins during the Sickness Syndrome Nih Public Access Author Manuscript Elevated Corticosteroid Levels , 2022 .

[15]  F. Di Virgilio,et al.  P2X7 receptor‐stimulation causes fever via PGE2 and IL‐1β release , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[16]  Christian Ehlting,et al.  The macrophage response towards LPS and its control through the p38(MAPK)-STAT3 axis. , 2012, Cellular signalling.

[17]  Ying Yu,et al.  Vascular COX-2 Modulates Blood Pressure and Thrombosis in Mice , 2012, Science Translational Medicine.

[18]  A. Matsuda,et al.  Pre-Treatment of Recombinant Mouse MFG-E8 Downregulates LPS-Induced TNF-α Production in Macrophages via STAT3-Mediated SOCS3 Activation , 2011, PloS one.

[19]  Y. Urade,et al.  Enzymes of the cyclooxygenase pathways of prostanoid biosynthesis. , 2011, Chemical reviews.

[20]  N. Kaushal,et al.  Selenoprotein-dependent Up-regulation of Hematopoietic Prostaglandin D2 Synthase in Macrophages Is Mediated through the Activation of Peroxisome Proliferator-activated Receptor (PPAR) γ* , 2011, The Journal of Biological Chemistry.

[21]  G. Graf,et al.  Cyclooxygenase-2 Deficiency Attenuates Adipose Tissue Differentiation and Inflammation in Mice , 2010, The Journal of Biological Chemistry.

[22]  G. FitzGerald,et al.  Cyclooxygenase-2–Dependent Prostacyclin Formation and Blood Pressure Homeostasis: Targeted Exchange of Cyclooxygenase Isoforms in Mice , 2010, Circulation research.

[23]  L. Lindgren,et al.  Bile high-mobility group box 1 contributes to gut barrier dysfunction in experimental endotoxemia. , 2009, American journal of physiology. Regulatory, integrative and comparative physiology.

[24]  Ying Yu,et al.  Renal and cardiovascular characterization of COX-2 knockdown mice. , 2009, American journal of physiology. Regulatory, integrative and comparative physiology.

[25]  F. Bosetti,et al.  Genetic deletion or pharmacological inhibition of cyclooxygenase‐1 attenuate lipopolysaccharide‐ induced inflammatory response and brain injury , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[26]  G. FitzGerald,et al.  Targeted Cyclooxygenase Gene (Ptgs) Exchange Reveals Discriminant Isoform Functionality* , 2007, Journal of Biological Chemistry.

[27]  G. FitzGerald,et al.  Differential impact of prostaglandin H synthase 1 knockdown on platelets and parturition. , 2005, The Journal of clinical investigation.

[28]  R. Botting,et al.  Cyclooxygenase Isozymes: The Biology of Prostaglandin Synthesis and Inhibition , 2004, Pharmacological Reviews.

[29]  B. Levy,et al.  Cyclooxygenase‐2 deficient mice are resistant to endotoxin‐induced inflammation and death , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[30]  R. Langenbach,et al.  Phenotypes of the COX-deficient mice indicate physiological and pathophysiological roles for COX-1 and COX-2. , 2002, Prostaglandins & other lipid mediators.

[31]  C. Funk,et al.  Prostaglandins and leukotrienes: advances in eicosanoid biology. , 2001, Science.

[32]  M. Murakami,et al.  Coupling between Cyclooxygenase, Terminal Prostanoid Synthase, and Phospholipase A2 * , 2001, The Journal of Biological Chemistry.

[33]  T. Standiford,et al.  Selective inhibition of COX-2 improves early survival in murine endotoxemia but not in bacterial peritonitis. , 2001, American journal of physiology. Lung cellular and molecular physiology.

[34]  C. Leslie,et al.  Intracellular Calcium Signals Regulating Cytosolic Phospholipase A2 Translocation to Internal Membranes* 210 , 2001, The Journal of Biological Chemistry.

[35]  Charles N. Serhan,et al.  Lipid mediator class switching during acute inflammation: signals in resolution , 2001, Nature Immunology.

[36]  B. Koller,et al.  Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes. , 2001, The Journal of clinical investigation.

[37]  R. Langenbach,et al.  Why there are two cyclooxygenase isozymes. , 2001, The Journal of clinical investigation.

[38]  S A Rich,et al.  The coxibs, selective inhibitors of cyclooxygenase-2. , 2001, The New England journal of medicine.

[39]  R. Garavito,et al.  Cyclooxygenases: structural, cellular, and molecular biology. , 2000, Annual review of biochemistry.

[40]  C. Cerletti,et al.  COX-2 is not involved in thromboxane biosynthesis by activated human platelets. , 1999, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[41]  R. Langenbach,et al.  Cyclooxygenase knockout mice: models for elucidating isoform-specific functions. , 1999, Biochemical pharmacology.

[42]  R. Langenbach,et al.  Cyclooxygenase‐deficient Mice: A Summary of Their Characteristics and Susceptibilities to Inflammation and Carcinogenesis , 1999, Annals of the New York Academy of Sciences.

[43]  R. Kulmacz,et al.  Hydroperoxide Dependence and Cooperative Cyclooxygenase Kinetics in Prostaglandin H Synthase-1 and -2* , 1999, The Journal of Biological Chemistry.

[44]  G. FitzGerald,et al.  Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[45]  J. Wallace,et al.  Cyclooxygenase 1 contributes to inflammatory responses in rats and mice: implications for gastrointestinal toxicity. , 1998, Gastroenterology.

[46]  I. Morita,et al.  Different substrate utilization between prostaglandin endoperoxide H synthase-1 and -2 in NIH3T3 fibroblasts. , 1998, Biochimica et biophysica acta.

[47]  J. Vane,et al.  Cyclooxygenases 1 and 2. , 1998, Annual review of pharmacology and toxicology.

[48]  D. Swinney,et al.  Differential Allosteric Regulation of Prostaglandin H Synthase 1 and 2 by Arachidonic Acid* , 1997, The Journal of Biological Chemistry.

[49]  J. Johnston,et al.  Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II , 1995, Nature.

[50]  Hyung-Suk Kim,et al.  Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration , 1995, Cell.

[51]  R. Langenbach,et al.  Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse , 1995, Cell.

[52]  J. D. Clark,et al.  Cytosolic phospholipase A2. , 1995, Journal of lipid mediators and cell signalling.

[53]  T. Kaneko,et al.  Dominant expression of mRNA for prostaglandin D synthase in leptomeninges, choroid plexus, and oligodendrocytes of the adult rat brain. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[54]  V. Winn,et al.  cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[55]  H R Herschman,et al.  Dexamethasone inhibits mitogen induction of the TIS10 prostaglandin synthase/cyclooxygenase gene. , 1992, The Journal of biological chemistry.

[56]  R. Erikson,et al.  Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[57]  G. FitzGerald,et al.  Analysis of prostacyclin and thromboxane biosynthesis in cardiovascular disease. , 1983, Circulation.

[58]  J. Vane,et al.  Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. , 1971, Nature: New biology.